Chief Medical Officer
Tadiso, Inc.
Zelienople, Pennsylvania
James R. Latronica, DO, DFASAM received his medical degree from the Philadelphia College of Osteopathic Medicine. He is Board Certified in Family Medicine and Addiction Medicine. He completed residency training at Clarion Hospital in Clarion, PA, then completed an Addiction Medicine Fellowship at Penn State.
He has a deep interest in activism and advocacy and serves as President of the Pennsylvania Society of Addiction Medicine, as a member off the American Society off Addiction Medicine’s (ASAM) Public Policy Committee, and also serves on the boards of the Pennsylvania Osteopathic Medical Association (POMA), and the Pennsylvania Medical Society (PAMED).
He has previously been awarded a Ruth Fox Memorial Scholarship Award from ASAM, an Excellence in Individual Advocacy Award from the American Osteopathic Association (AOA), a State Emerging Leader Award from POMA, and a Top Physicians Under 40 Award from PAMED.
He has various publications on prescription stimulants and Stimulant Use Disorder, and his lay writing and interviews on addiction and harm reduction have appeared in both regional and national outlets.
After four years as an Assistant Professor of Psychiatry and Family Medicine at the University of Pittsburgh School of Medicine, he is now the Chief Medical Officer or Tadiso, Inc., the largest and oldest OTP in Pittsburgh.
PC14 - Opioid Treatment Programs in 2025: Modernization and Mobile Unit Rollouts
Sunday, October 5, 2025
1:00pm - 3:00pm EST